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Editorial
D uring the past two decades, Iran has witnessed a positive trend in both input and output of medical research.1–4 The 
amount of expenditure in scienti¿c research has increased 
from 0.55% to 0.87% of the GDP between 2001 and 2009, and the 
set target is 2.5% to be achieved by 2015 and 4% in 2030.5 Iran also 
plans to increase its education spending from 5.49% in 2007 to 
over 7% in 2030.6 The number of publications from Iran has in-
creased from 5034 in 1996 to 20244 in 2008. This 18-fold increase 
outstrips that of any other country in the region.7,8 This increase in 
output has been accompanied by an increase in citations over the 
same time period,1-4 and an increase in the number of Iranian jour-
nals indexed in internationally recognized databases.9 One of the 
major activities at the Deputy for Research at Ministry of Health 
and Medical Education(MOHME) was the establishment of a reg-
ular research system, evaluation and monitoring, and an emphasis 
on research translation into innovation. 
Research system evaluation and monitoring has an important role 
in the recent performance of Iranian medical universities and the 
Health System Research Institute. Evaluation can hold researchers 
and research institutes accountable for the research projects they 
design and launch, in addition to the research results they report. 
In the same context, the feedback attained through research evalu-
ation can be applied in steering decision-making at the level of 
individuals, institutes, and the entire health system. This feedback 
can further show the strengths and weaknesses of the research sys-
tem, which can justify the monetary and human resources that are 
spent on research. In short, it can help develop and strengthen the 
research infrastructure at all levels of the health system.10
A paper by Peykari et al. presents the methodology and results 
of the ¿ve-year evaluation that has been, for the ¿rst time, devised 
and implemented in Iran. This evaluation method encompasses in-
dicators advocated by the WHO and UNESCO and has been spe-
ci¿cally tailored for the Health Research System (HRS) in Iran. 
As properly mentioned in the paper, the prominent strengths of 
this method can be summarized into its participatory process and 
its dynamism. The results of the evaluation reveal improvement in 
almost all indicators that have been measured in this study, from 
2003 to 2008.
Evaluation methods, if not carefully designed and implemented, 
may lead to substantial bias in the results they release. The current 
method is likewise not spared from bias. The sources of bias em-
bedded in this study originate from: 1) Methods of data collection 
and 2) the speci¿c indicators that have been selected to evaluate 
HRS in Iran.
In the ¿rst category, the main defect is absence of the peer re-
view process in the evaluation of HRS. Professional peer review is 
widely accepted and adopted in health research.11 It is the mainstay 
for approving research projects before their conduct and validat-
ing research results before their publication and dissemination.12 
Peer review is likewise an indispensable component of research 
process evaluation. It is dif¿cult for researchers, whether individu-
ally or in a team, to spot every mistake or Àaw in their works. An 
opportunity for improvement may be more obvious to someone 
with special expertise. Showing research to others who look at the 
work with a fresh eye increases the probability that weaknesses 
be identi¿ed and improved. In the evaluation method described 
by Peykari et al., the absence of peer reviewers to independently 
evaluate research centers is evident.
Even more appalling is the absence of well-quali¿ed external ex-
perts in the HRS evaluation reported by Peykari et al. There are 
numerous experts in this ¿eld in our country who could be inde-
pendent and unbiased referees in the evaluation process. Exter-
nal experts are not restricted to Iranians. We could bene¿t from 
international professionals. As Iran is mounting the ¿rst steps in 
expanding its health research infrastructure, taking advantage of 
experiences that have been successful in countries with more de-
veloped HRS could considerably reduce the risk of our mistakes.
The Àaw is not limited to neglecting external individual experts 
and peer reviewers in this study. The baseline data for HRS evalu-
ation have been collected by medical science universities per se 
rather than by individual independent evaluators, and have been 
subsequently reported to the Deputy of Research and Technology 
in the Ministry of Health. It is worth noting that almost all of these 
evaluators are directors of their af¿liated medical science universi-
ties and have been biased towards the performance of their own 
research body. 
In the second category of sources of bias, the speci¿c indicators 
selected for HRS evaluation should be discussed. In the steward-
ship axis, three indicators have been measured: priority setting, 
strategic planning, and establishment of an ethics committee. It 
has been announced by the Deputy of Research and Technology 
that medical universities will be evaluated by these three criteria. It 
is obvious that none of the universities would have neglected this 
rule and all have reported that they meet the criteria: priorities have 
been set, strategic plans developed, and ethics committees estab-
lished. However, there is no way to qualitatively assess the actual 
function of a university in these domains.    
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Other indicators in the other two axes, capacity building and 
knowledge production, are similarly quantitative rather than quali-
tative. Capacity building indicators focus on number of workshops 
and congresses and do not reÀect the real “capacity”, or the real en-
vironment, which may have been built for research and research-
ers. Indicators in knowledge production are likewise bibliometric 
and do not reÀect the actual quality of the research products.
In conclusion, the possibility for removing these Àaws should be 
reviewed. The ¿rst category of biases mentioned above completely 
relate to the processes that have been adopted for data collection. 
All of these defects can be eliminated through careful and precise 
planning. Involving peer reviewers, external independent experts, 
and unbiased of¿cials in HRS evaluation will not only certify the 
validity of our evaluation process, it will also enrich our medical 
research culture and will bring us closer to the ultimate goal of our 
HRS evaluation, which is building a health research infrastructure. 
The second category of biases, the fact that indicators are mainly 
quantitative and evaluate knowledge production rather than trans-
lation, is not entirely the defect of this evaluation system. This de-
fect also originates in the underdeveloped health infrastructure in 
our country. There is no valid way to measure what fraction of our 
research results are translated into improved healthcare services. 
We cannot ensure that research results produced in developed 
countries be reÀected in our medical practice. Therefore, although 
it is necessary to guide strategies based on local research results, 
we may still bene¿t if we focus on more effective knowledge trans-
lation in our country.
Despite all of the aforementioned arguments, this ¿rst attempt 
aimed at evaluating the HRS in Iran can be invaluable for the en-
richment of our healthcare and the health research infrastructure 
through its subsequent improvements. 
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